D-dimer level influences thromboembolic events in patients with atrial fibrillation

International Journal of Cardiology

Volumn 109, Issue 1, 2006, Pages 59-65

  Nozawa, Takashi ^a   Inoue, Hiroshi ^a   Hirai, Tadakazu ^a   Iwasa, Atsushi ^b   Okumura, Ken ^b   Lee, Jong Dae ^c   Shimizu, Akihiko ^d   Hayano, Motonobu ^e   Yano, Katsusuke ^e  

^a UNIVERSITY OF TOYAMA   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

^d YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NAGASAKI UNIVERSITY   (Japan)

Author keywords

Anticoagulants; Atrial fibrillation; Stroke prevention; Thromboembolism

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA THROMBOGLOBULIN; D DIMER; PROTHROMBIN; THROMBOCYTE FACTOR 4; WARFARIN;

ADULT; AGED; ARTICLE; BLEEDING; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; STROKE; SURVIVAL RATE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; UNIVARIATE ANALYSIS;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; BETA-THROMBOGLOBULIN; BIOLOGICAL MARKERS; CEREBROVASCULAR ACCIDENT; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIDE FRAGMENTS; PLATELET FACTOR 4; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTHROMBIN; THROMBOEMBOLISM; WARFARIN;

EID: 33645388630     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.05.049     Document Type: Article

References (19)

1. Stroke Prevention in Atrial Fibrillation Investigators Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial Lancet 348 1996 633 638
2. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation N Engl J Med 1323 1990 1505 1511
3. M.D. Ezekowitz, S.L. Bridgers, K.E. James for the Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation N Engl J Med 327 1992 1406 1412
4. T. Yamaguchi for Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation. A multicenter, prospective, randomized trial Stroke 31 2000 817 821
5. C. Gustafsson, M. Blomback, M. Britton, A. Hamsten, and J. Svensson Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation Stroke 21 1990 47 51
6. G.Y.H. Lip, P.L. Lip, and J. Zarifis Fibrin D-dimer and β-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin Circulation 94 1996 425 431
7. G.Y.H. Lip, G.D.O. Lowe, A. Rumley, and F.G. Dunn Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment Br Heart J 73 1995 527 533
8. F.L. Li-Saw-Hee, A.D. Blann, and G.Y.H. Lip Effects of low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation Stroke 31 2000 828 833
9. T. Nozawa, H. Inoue, and A. Iwasa Effects of anticoagulation intensity on hemostatic markers in patients with non-valvular atrial fibrillation Circ J 68 2004 29 34
10. M. Somloi, J. Tomcsanyi, E. Nagy, I. Bodo, and A. Bezzegh D-dimer determination as a screening tool to exclude atrial thrombi in atrial fibrillation Am J Cardiol 92 2003 85 87
11. N. Vene, A. Mavri, K. Kosmelj, and M. Stegnar High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy Thromb Haemost 90 2003 1163 1172
12. W.M. Feinberg, L.A. Pearce, R.G. Hart for the Stroke Prevention in Atrial Fibrillation Investigators Markers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the Stroke Prevention in Atrial Fibrillation III Study Stroke 30 1999 2547 2553
13. H. Inoue, T. Nozawa, K. Okumura, J.D. Lee, A. Shimizu, and K. Yano Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism Chest 126 2004 687 692
14. R.L. McNamara, L.M. Brass, and J.P. Drozda Jr. ACC/AHA Key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association task force on clinical data standards (writing committee to develop data standards on atrial fibrillation) J Am Coll Cardiol 44 2004 475 495
15. The Stroke Prevention in Atrial Fibrillation Investigators Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk Ann Intern Med 116 1992 1 5
16. Atrial Fibrillation Investigators Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials Arch Intern Med 154 1994 1449 1457
17. A.J. Furlan, A.R. Craciun, N.R. Raju, and N. Hart Cerebrovascular complications associated with idiopathic hypertrophic subaortic stenosis Stroke 15 1984 282 284
18. K. Yamamoto, U. Ikeda, K. Furuhashi, M. Irokawa, T. Nakayama, and K. Shimada The coagulation system is activated in idiopathic cardiomyopathy J Am Coll Cardiol 25 1995 1634 1640
19. D. Feng, R.B. D'Agostino, and H. Silbershatz Hemostatic state and atrial fibrillation (The Framingham Offspring Study) Am J Cardiol 87 2001 168 171